Skip To Main Content

Search

For optimal search results, please limit to 2 product keywords

If you are searching for information related to a product:

  • For optimal results, please enter at least 2 search terms in addition to product name
  • Example: [product name] [search term] [search term]
  • Example: Product + clinical trials
  • For an exact match, please include search terms in double quotations. For example: "health equity"

    Search engine improvements are ongoing. Searches matching medical information letters may appear first. Keep scrolling for more results.

    Please enter search terms.

    Our Oncology Portfolio

    Find product and prescribing information, as well as other resources, for Genentech’s oncology portfolio below.

    A

    Alecensa®

    (alectinib)

    View Product Page

    Avastin®

    (bevacizumab)

    Prescribing Information

    Safety Data Sheets:

    AVASTIN® Vials (100 mg)
    AVASTIN® Vials (400 mg)

    Healthcare Provider Letters:

    Important Drug Warning: Necrotizing Fasciitis - Apr 2013
    Warning for Counterfeit Product Labeled as Avastin in the United States Feb 2012
    Important Change to Avastin® label for treatment of metastatic breast cancer - Nov 2011
    Important New Safety Information in Women Receiving AVASTIN - Oct 2011
    Intraocular Inflammatory Reactions - Dec 2008
    Microangiopathic Hemolytic Anemia (MAHA) - July 2008
    Tracheoesophageal (TE) Fistula - April 2007
    Cases of RPLS in Patients Receiving AVASTIN - Sept 2006
    VEGF antibodies for the treatment of retinopathy of prematurity - Aug 2006

    C

    Columvi®

    (glofitamab-gxbm)

    View Product Page

    Cotellic®

    (cobimetinib)

    Prescribing Information
    Important Patient Information

    Safety Data Sheets:

    COTELLIC Tablets (20 mg)

    E

    Erivedge®

    (vismodegib)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    ERIVEDGE® Capsules (150 mg)

    Healthcare Provider Letters:

    Important Drug Warning - November 2016
    Serious Risk with Use of Erivedge (vismodegib) Capsules: Premature Epiphyseal Fusion - June 2016
    Extension of Pregnancy Prevention Duration for Women of Childbearing Potential and Waiting Periods for Blood Donations and Lactation in Patients taking ERIVEDGE (vismodegib) capsule - February 2016

    G

    Gazyva®

    (obinutuzumab)

    Prescribing Information

    Safety Data Sheets:

    GAZYVA® Vials (1000 mg/40 mL)

    Healthcare Provider Letter:

    Gazyva™ (obinutuzumab) Important Drug Warning: Thrombocytopenia - Feb 2014

    H

    Herceptin®

    (trastuzumab)

    Prescribing Information

    Safety Data Sheets:

    HERCEPTIN® Vials (150 mg)

    Healthcare Provider Letters:

    440mg Vials and Herceptin BWFI Diluent - June 2008
    Updated Cardiotoxicity Information - Aug 2005
    Fatal Embryo-Fetal Toxicity due to Herceptin Exposure During Pregnancy

    Herceptin Hylecta™

    (trastuzumab and hyaluronidase-oysk)

    Prescribing Information

    Safety Data Sheets:

    HERCEPTIN HYLECTA™ Vials (600 mg/5 mL)

    I

    Itovebi™

    (inavolisib)

    View Product Page

    K

    Kadcyla®

    (ado-trastuzumab emtansine)

    Prescribing Information

    Safety Data Sheets:

    KADCYLA® Lyophilized Powder in Vials (100 mg)
    KADCYLA® Lyophilized Powder in Vials (160 mg)
    KADCYLA® Solution

    Healthcare Provider Letters:

    Kadcyla Important Safety Warning: Hemorrhage - Nov 2013
    KADCYLA (ado-trastuzumab emtansine) error on the carton - May 2013

    L

    Lunsumio®

    (mosunetuzumab-axgb)

    View Product Page

    P

    Perjeta®

    (pertuzumab)

    Prescribing Information

    Safety Data Sheets:

    PERJETA® (420 mg)

    Phesgo®

    (pertuzumab, trastuzumab, and hyaluronidase-zzxf)

    Prescribing Information

    Safety Data Sheets:

    PHESGO® (pertuzumab, trastuzumab & hyaluronidase-zzxf) Injection (60 mg/mL, 60 mg/mL)
    PHESGO® (pertuzumab, trastuzumab & hyaluronidase-zzxf) Injection (80 mg/mL, 40 mg/mL)

    Polivy®

    (polatuzumab vedotin-piiq)

    View Product Page

    R

    Rituxan®

    (rituximab)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    RITUXAN® Vials (100 mg/10 mL)
    RITUXAN® Vials (500 mg/50 mL)

    Healthcare Provider Letters:

    Rituxan® (rituximab) Label: Hepatitis B Reactivation - October 2013
    Important Drug Warning: Updated Safety Information - Dec 2006
    Important Drug Warning: New Safety Information - Sept 2008
    Important Drug Warning: Updated Safety Information - Oct 2009

    Rituxan Hycela®

    (rituximab and hyaluronidase human)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    RITUXAN HYCELA® Vials (1600 mg)
    RITUXAN HYCELA® Vials (1400 mg)

    Rozlytrek®

    (entrectinib)

    Prescribing Information
    Important Patient Information

    Safety Data Sheets:

    ROZLYTREK® Capsules (100 mg)
    ROZLYTREK® Capsules (200 mg)

    T

    Tarceva®

    (erlotinib)

    Prescribing Information

    Safety Data Sheets:

    TARCEVA® Tablets (25 mg)
    TARCEVA® Tablets (100 mg)
    TARCEVA® Tablets (150 mg)

    Healthcare Provider Letters:

    Important Prescribing Information - October 2016
    Important Correction of Drug Information - June 2016

    Tecentriq®

    (atezolizumab)

    View Product Page

    Tecentriq Hybreza™

    (atezolizumab and hyaluronidase-tqjs)

    View Product Page

    V

    Venclexta®

    (venetoclax)

    View Product Page

    X

    Xeloda®

    (capecitabine)

    Prescribing Information
    Important Patient Information

    Safety Data Sheets:

    XELODA® Tablets (150 mg)
    XELODA® Tablets (500 mg)

    Z

    Zelboraf®

    (vemurafenib)

    Prescribing Information
    Medication Guide

    Safety Data Sheets:

    ZELBORAF® F.C. Tablets (240 mg)

    Healthcare Provider Letters:

    Important Drug Warning - June 2017
    Important Drug Warning - March 2014
    Important Drug Warning - August 2013
    Publications icon

    Publications

    Visit PubMed.gov to view scientific literature for Genentech oncology portfolio products.

    Avastin® at PubMed.gov

    Cotellic® at PubMed.gov

    Erivedge® at PubMed.gov

    Gazyva® at PubMed.gov

    Herceptin® at PubMed.gov

    Kadcyla® at PubMed.gov

    Perjeta® at PubMed.gov

    Phesgo® at PubMed.gov

    Rituxan® at PubMed.gov

    Rozlytrek® at PubMed.gov

    Xeloda® at PubMed.gov

    Zelboraf® at PubMed.gov

    Scientific congresses icon

    Scientific Congresses

    Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

    Clinical trials icon

    Clinical Trials

    Find information about active clinical research for Genentech oncology portfolio products.

    Avastin® at ClinicalTrials.gov

    Cotellic® at ClinicalTrials.gov

    Erivedge® at ClinicalTrials.gov

    Gazyva® at ClinicalTrials.gov

    Herceptin® at ClinicalTrials.gov

    Kadcyla® at ClinicalTrials.gov

    Perjeta® at ClinicalTrials.gov

    Phesgo® at ClinicalTrials.gov

    Rituxan® at ClinicalTrials.gov

    Rozlytrek® at ClinicalTrials.gov

    Xeloda® at ClinicalTrials.gov

    Zelboraf® at ClinicalTrials.gov

    Additional resources icon

    Additional Resources

    Connect with a Medical Science Liaison

    Browse the Genentech Medical Information Library